Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-03-30 4:43 pm Purchase | 2023-03-23 | 13G | Harpoon Therapeutics, Inc. HARP | New Leaf Ventures III L.P. | 624,847 15.400% | 299,431 (+92.01%) | Filing History |
| 2023-03-29 4:27 pm Purchase | 2023-03-23 | 13D | Harpoon Therapeutics, Inc. HARP | Arix Bioscience plc | 323,893 8.400% | 104,801 (+47.83%) | Filing History |
| 2023-02-14 4:25 pm Sale | 2022-12-31 | 13G | Harpoon Therapeutics, Inc. HARP | ORBIMED ADVISORS LLC | 80,421 2.400% | -86,369 (-51.78%) | Filing History |
| 2023-02-06 4:32 pm Purchase | 2022-12-31 | 13G | Harpoon Therapeutics, Inc. HARP | New Leaf Ventures III L.P. | 325,416 9.800% | 4,231 (+1.32%) | Filing History |
| 2023-01-18 4:16 pm Purchase | 2023-01-12 | 13G | Harpoon Therapeutics, Inc. HARP | INTEGRATED CORE STRATEGIES (US) LLC | 197,027 5.900% | 197,027 (New Position) | Filing History |
| 2022-07-08 4:56 pm Sale | 2022-06-30 | 13G | Harpoon Therapeutics, Inc. HARP | BlackRock Inc. BLK | 94,048 2.800% | -77,386 (-45.14%) | Filing History |
| 2022-02-15 08:37 am Sale | 2021-12-31 | 13G | Harpoon Therapeutics, Inc. HARP | Logos Global Management LP | 150,000 4.600% | -33,000 (-18.03%) | Filing History |
| 2022-02-11 4:58 pm Purchase | 2021-12-31 | 13G | Harpoon Therapeutics, Inc. HARP | New Leaf Ventures III L.P. | 321,186 9.800% | 28,553 (+9.76%) | Filing History |
| 2022-02-11 4:26 pm Purchase | 2021-12-31 | 13G | Harpoon Therapeutics, Inc. HARP | ORBIMED ADVISORS LLC | 166,790 5.100% | 64,720 (+63.41%) | Filing History |
| 2022-02-04 4:12 pm Purchase | 2021-12-31 | 13G | Harpoon Therapeutics, Inc. HARP | BlackRock Inc. BLK | 171,433 5.200% | 31,903 (+22.86%) | Filing History |
| 2021-12-27 5:25 pm Purchase | 2021-12-17 | 13G | Harpoon Therapeutics, Inc. HARP | Logos Global Management LP | 183,000 5.600% | 183,000 (New Position) | Filing History |
| 2021-07-15 5:41 pm Sale | 2021-07-06 | 13D | Harpoon Therapeutics, Inc. HARP | Arix Bioscience plc | 219,092 6.700% | -1,775 (-0.80%) | Filing History |
| 2021-05-06 06:15 am Sale | 2021-04-30 | 13D | Harpoon Therapeutics, Inc. HARP | MPM BioVentures 2014 L.P. | 656,146 20.200% | -57,527 (-8.06%) | Filing History |
| 2021-02-16 08:30 am Sale | 2021-01-27 | 13D | Harpoon Therapeutics, Inc. HARP | MPM BioVentures 2014 L.P. | 713,673 22.300% | -128,612 (-15.27%) | Filing History |
| 2021-02-12 4:49 pm Sale | 2020-12-31 | 13G | Harpoon Therapeutics, Inc. HARP | ORBIMED ADVISORS LLC | 102,070 4.020% | -34,000 (-24.99%) | Filing History |
| 2021-02-10 3:04 pm Purchase | 2021-01-31 | 13G | Harpoon Therapeutics, Inc. HARP | BlackRock Inc. BLK | 139,531 4.400% | 3,109 (+2.28%) | Filing History |
| 2021-02-02 3:13 pm Purchase | 2020-12-31 | 13G | Harpoon Therapeutics, Inc. HARP | BlackRock Inc. BLK | 136,421 5.400% | 136,421 (New Position) | Filing History |
| 2021-01-12 4:15 pm Purchase | 2021-01-11 | 13D | Harpoon Therapeutics, Inc. HARP | Arix Bioscience plc | 220,867 6.900% | 1,496 (+0.68%) | Filing History |
| 2020-06-01 5:00 pm Sale | 2020-05-27 | 13D | Harpoon Therapeutics, Inc. HARP | Arix Bioscience plc | 219,370 8.800% | -41,521 (-15.92%) | Filing History |